
On February 17th, a long-discussed plan to have the Russian Alcohol Regulator (RAR) take control of the tobacco market in Russia is slowly being put into effect. The Russian Ministry of Finance plans to submit the relevant legislation to the State Duma at the end of February or beginning of March.
George Golovanov, Deputy Minister and State Counselor for the Russian Ministry of Finance, has announced plans to expand the regulatory powers of the Federal Service for the Regulation of Alcohol and Tobacco (RAR) to cover nicotine-containing products. The new agency may be referred to as the "Russian Alcohol and Tobacco Control Bureau.
Furthermore, RAR is planning to utilize two information systems. Alongside the current use of the federal product traceability system (EGAIS), the tobacco sector will also adopt the goods circulation supervision information system (for products that require mandatory labeling) to support the initiative. Currently, a mandatory labeling system for cigarettes is enforced under the name "Honest Label".
In response to concerns from the public about issues such as when new measures will be announced and when management control will be transferred to RAR, Golovanov stated that this information will be released after the bill is passed by the State Duma. The bill proposes a series of measures to improve regulation of the tobacco market and is expected to be submitted to the State Duma in late February to early March. During the regulatory amendment phase, RAR's functions will be expanded because these regulations will include provisions regarding the Ministry of Finance and the Russian Federal Alcohol Regulation Agency.
References:
The suggestion has been made to transform Rosalcoholregulation into Rosalcoholtobaccocontrol.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.









